LifeTech Scientific Corporation has announced a strategic equity investment in Affector Medtech (Suzhou) Ltd., a high-tech company in China specializing in electrophysiology and innovative medical devices. The investment, totaling RMB150 million, will be made through LifeTech's wholly-owned subsidiary, Lifetech Scientific (Shenzhen) Co., Ltd., and will be disbursed in stages contingent upon the achievement of specific milestones, such as securing employment contracts and obtaining necessary regulatory approvals from the China National Medical Products Administration. The investment will be financed through the Group's internal resources and does not constitute a notifiable or connected transaction under Hong Kong's listing rules.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。